Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients
Authors:
- 29 May 2010
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 25 (3) , 195-202
Abstract
We prospectively evaluated long-term (12 months) effects of telmisartan on blood pressure (BP), circulating renin-anigiotensin-aldosterone levels, and lipids in hypertensive patients. There were 13 men and 11 women, 59 ± 8.7 years of age (mean ± SEM), with untreated essential hypertension. The 20-60 mg doses of telmisartan were administered once daily in the morning until BP130/85 was obtained. Blood pressure and plasma renin activity, plasma angiotensin (Ang) I and Ang II, serum angiotensin-converting enzyme (ACE) activity, plasma aldosterone concentration, plasma human atrial natriuretic peptide (hANP) concentration, and serum lipids were obtained 6 and 12 months after starting telmisartan administration. Systolic and diastolic BP were significantly (P < 0.001, P < 0.001) decreased from 162 ± 3.3 and 97.7 ± 2.1 mmHg to 128 ± 3.8 and 79.6 ± 2.0 mmHg after 12 months of treatment, respectively. Plasma Ang I and Ang II were unchanged at 12 months. Plasma renin activity and serum ACE activity were significantly (P < 0.001, P < 0.05) increased and plasma aldosterone concentration was unchanged during the study period. Total cholesterol levels were unchanged, but serum triglycerides levels were significantly decreased at 12 months (P < 0.01). Plasma hANP showed no significant alteration throughout the 12-month period. In hypertensive patients, telmisartan is a beneficial antihypertensive drug that also lowers serum triglycerides.Keywords
This publication has 40 references indexed in Scilit:
- Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect?Current Opinion in Pharmacology, 2007
- Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptorsKidney International, 2005
- PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce AdiponectinHypertension, 2005
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Cardioprotective Role of AT2 Receptor in Postinfarction Left Ventricular RemodelingHypertension, 2003
- TelmisartanDrugs, 2001
- Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive PatientsHypertension, 1995
- Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin systemAmerican Heart Journal, 1994
- Changes in plasma atrial natriuretic polypeptide concentration during head-out water immersion and saline infusion in normal men.Japanese Heart Journal, 1987